Skip to main content
FinSpry Logo
FinSpry
HAE logo
HAE
(NYSE)
Haemonetics Corporation
$72.78-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Haemonetics (HAE) Stock Price & Financial Analysis

Haemonetics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$72.29 - $74.53
52-Week High$87.32
52-Week Low$47.32
Open$73.17
Volume884.31K
Average Volume (3M)1.04M
Market Cap3.36B
Shares Outstanding46.22M
P/E Ratio (TTM)34.57
Forward P/E60.97
Price to Sales (P/S)2.52
Price to Book (P/B)4.22
EV/EBITDA15.50
Revenue (TTM)1.33B
Net Income (TTM)97.31M
Free Cash Flow (TTM)260.44M
EPS (TTM)$2.06
Profit Margin7.29%
Operating Margin18.15%
Return on Equity (ROE)12.22%
Debt to Equity1.54
50-Day MA$63.97
200-Day MA$63.99
52-Week Change0.99%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Haemonetics

What is the current stock price for HAE?

As of the latest trading session, HAE stock trades at $74.17. The 52-week range is $47.32–$87.32, with a day range of $72.29–$74.53.

What is the P/E ratio for HAE?

Haemonetics's trailing P/E ratio is 34.6, meaning investors pay $34.6 for every $1 of annual earnings. The forward P/E is 61.0, reflecting analyst expectations for future earnings. Haemonetics operates in the Healthcare sector.

Does HAE pay dividends?

Haemonetics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for HAE?

Based on 8 analysts, the consensus for HAE is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of HAE?

Haemonetics's market capitalization is $3.43B, classifying it as a mid-cap company. Haemonetics operates in the Healthcare sector within the Medical Devices industry.